The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
NeoImmuneTech
Genmab
BioInvent International AB
Essen Biotech
BicycleTx Limited
Maastricht University Medical Center
Eli Lilly and Company
Mayo Clinic
NextCure, Inc.
Sellas Life Sciences Group
NGM Biopharmaceuticals, Inc
ENB Therapeutics, Inc
Sumitomo Pharma America, Inc.
Kineta Inc.
Tesaro, Inc.
University of Washington
Incyte Corporation
Aduro Biotech, Inc.